Publications by authors named "Zunyan Dai"

37Publications

[Standards and regulations for reporting clinical genetic testing results in the United States].

Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2019 Jan;36(1):65-91

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA O2115, USA. Email:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3760/cma.j.issn.1003-9406.2019.01.011DOI Listing
January 2019

Haploinsufficiency of HDAC4 does not cause intellectual disability in all affected individuals.

Am J Med Genet A 2014 Jul 8;164A(7):1826-9. Epub 2014 Apr 8.

Divison of Genetics, Nemours Children's Clinic, Orlando, Florida.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajmg.a.36542DOI Listing
July 2014

Deletions of the PRKAR1A locus at 17q24.2-q24.3 in Carney complex: genotype-phenotype correlations and implications for genetic testing.

J Clin Endocrinol Metab 2014 Jan 20;99(1):E183-8. Epub 2013 Dec 20.

Section on Endocrinology and Genetics (P.S., E.L., F.R.F., I.L., E.G., M.F.K., C.L., C.A.S.), Program on Developmental Endocrinology and Genetics and Pediatric Endocrinology Inter-institute Training Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892; Department of Biochemistry and Molecular Medicine (A.H.), The George Washington University, Washington, D.C. 20037; Department of Molecular Medicine (A.V., A.F., O.Z.), University of Pavia, Pavia 27100, Italy; Division of Genetics and Endocrinology (A.D., I.A.H.), Boston Children's Hospital, Boston, Massachusetts; Regional Medical Genetics Center (P.J.M.), Queens University Belfast, Belfast BT9 7AB, United Kingdom; and Quest Diagnostics Nichols Institute (E.D.S., M.A.S., J.C.K., Z.D., P.M.), Chantilly, Virginia 20151.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2013-3159DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3879675PMC
January 2014

A common spinal muscular atrophy deletion mutation is present on a single founder haplotype in the US Hutterites.

Eur J Hum Genet 2011 Oct 25;19(10):1045-51. Epub 2011 May 25.

Department of Human Genetics, The University of Chicago, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ejhg.2011.85DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3190247PMC
October 2011

Genotyping panel for assessing response to cancer chemotherapy.

BMC Med Genomics 2008 Jun 11;1:24. Epub 2008 Jun 11.

Program in Pharmacogenomics, Department of Pharmacology, Comprehensive Cancer Center, College of Medicine and Public Health, The Ohio State University, 5072 Graves Hall, 333 West 10th Avenue, Columbus, OH 43210-1239, USA.

View Article

Download full-text PDF

Source
http://bmcmedgenomics.biomedcentral.com/articles/10.1186/175
Publisher Site
http://dx.doi.org/10.1186/1755-8794-1-24DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2442111PMC
June 2008

MicroRNAs modulate the chemosensitivity of tumor cells.

Mol Cancer Ther 2008 Jan 9;7(1):1-9. Epub 2008 Jan 9.

Program of Pharmacogenomics, Department of Pharmacology, Ohio State University, 333 West Tenth Street, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-07-0573DOI Listing
January 2008

Cystine-glutamate transporter SLC7A11 mediates resistance to geldanamycin but not to 17-(allylamino)-17-demethoxygeldanamycin.

Mol Pharmacol 2007 Dec 17;72(6):1637-46. Epub 2007 Sep 17.

Division of Pharmacogenomics and Molecular Epidemiology, National Center for Toxicological Research, Food and Drug Administration, Jefferson, Arkansas, USA.

View Article

Download full-text PDF

Source
http://molpharm.aspetjournals.org/cgi/doi/10.1124/mol.107.03
Publisher Site
http://dx.doi.org/10.1124/mol.107.039644DOI Listing
December 2007

MicroRNA expression profiles for the NCI-60 cancer cell panel.

Mol Cancer Ther 2007 May 4;6(5):1483-91. Epub 2007 May 4.

Program of Pharmacogenomics, Department of Pharmacology and the Comprehensive Cancer Center, College of Medicine, The Ohio State University, 5072 Graves Hall, 333 West 10th Avenue, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-07-0009DOI Listing
May 2007

Chemogenomic analysis identifies geldanamycins as substrates and inhibitors of ABCB1.

Pharm Res 2007 Sep 25;24(9):1702-12. Epub 2007 Apr 25.

Department of Pharmaceutical Sciences, College of Pharmacy, Western University of Health Sciences, Pomona, CA 91766, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11095-007-9300-x
Publisher Site
http://dx.doi.org/10.1007/s11095-007-9300-xDOI Listing
September 2007

Chemoinformatics analysis identifies cytotoxic compounds susceptible to chemoresistance mediated by glutathione and cystine/glutamate transport system xc-.

J Med Chem 2007 Apr 17;50(8):1896-906. Epub 2007 Mar 17.

Program of Pharmacogenomics, Department of Pharmacology and the Comprehensive Cancer Center, College of Medicine, The Ohio State University, Columbus Ohio 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/jm060960hDOI Listing
April 2007

5-Aza-2'-deoxycytidine and depsipeptide synergistically induce expression of BIK (BCL2-interacting killer).

Biochem Biophys Res Commun 2006 Dec 18;351(2):455-61. Epub 2006 Oct 18.

Program of Pharmacogenomics, Department of Pharmacology, The Ohio State University, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2006.10.055DOI Listing
December 2006

A pharmacoproteomics study of the cancer cell line EKVX using capillary-LC/MS/MS.

Mol Pharm 2006 Sep-Oct;3(5):566-78

Barnett Institute, Northeastern University, 360 Huntington Avenue, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://pubs.acs.org/doi/abs/10.1021/mp060002b
Publisher Site
http://dx.doi.org/10.1021/mp060002bDOI Listing
January 2007

Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia.

Cancer Chemother Pharmacol 2007 Mar 12;59(4):495-505. Epub 2006 Aug 12.

Division of Pharmaceutics, School of Pharmacy, The Ohio State University, 500 W. 12th Ave, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-006-0291-9DOI Listing
March 2007

Prediction of anticancer drug potency from expression of genes involved in growth factor signaling.

Pharm Res 2006 Feb 26;23(2):336-49. Epub 2006 Jan 26.

Program of Pharmacogenomics, Department of Pharmacology, The Ohio State University, 5078 Graves Hall, 333 West 10th Avenue, Columbus, 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11095-005-9260-yDOI Listing
February 2006

Pharmacogenetics/genomics and personalized medicine.

Hum Mol Genet 2005 Oct;14 Spec No. 2:R207-14

Department of Pharmacology, Comprehensive Cancer Center, College of Medicine and Public Health, The Ohio State University, Columbus, OH 43210-1239, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/hmg/ddi261DOI Listing
October 2005

Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistance.

Cancer Res 2005 Aug;65(16):7446-54

Program of Pharmacogenomics, Department of Pharmacology, Comprehensive Cancer Center, Ohio State University, Columbus, Ohio 43210-1239, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-04-4267DOI Listing
August 2005

Efflux of depsipeptide FK228 (FR901228, NSC-630176) is mediated by P-glycoprotein and multidrug resistance-associated protein 1.

J Pharmacol Exp Ther 2005 Apr 5;313(1):268-76. Epub 2005 Jan 5.

Division of Pharmaceutics, College of Pharmacy, The Ohio State Univeristy, Columbus, Ohio 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1124/jpet.104.072033DOI Listing
April 2005

Growth factor signaling and resistance to cancer chemotherapy.

Curr Top Med Chem 2004 ;4(13):1347-56

Program of Pharmacogenomics, Department of Pharmacology, College of Medicine and Public Health, The Ohio State University, 5168 Graves Hall, 333 West 10th Avenue, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1568026043387746DOI Listing
November 2004

Membrane transporters and channels: role of the transportome in cancer chemosensitivity and chemoresistance.

Cancer Res 2004 Jun;64(12):4294-301

Program of Pharmacogenomics, Department of Pharmacology, College of Medicine and Public Health, The Ohio State University, Columbus, 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-03-3884DOI Listing
June 2004

Bone morphogenetic protein 3B silencing in non-small-cell lung cancer.

Oncogene 2004 Apr;23(20):3521-9

Human Cancer Genetics Program, Department of Molecular Virology, Immunology and Medical Genetics, The Ohio State University, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1207441DOI Listing
April 2004

5-aza-2'-deoxycytidine activates the p53/p21Waf1/Cip1 pathway to inhibit cell proliferation.

J Biol Chem 2004 Apr 13;279(15):15161-6. Epub 2004 Jan 13.

Department of Biochemistry and Molecular Biology, University of Health Science Center, Beijing, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M311703200DOI Listing
April 2004

Methylation of adjacent CpG sites affects Sp1/Sp3 binding and activity in the p21(Cip1) promoter.

Mol Cell Biol 2003 Jun;23(12):4056-65

Department of Internal Medicine. Department of Pathology, The Ohio State University-Comprehensive Cancer Center, Columbus, Ohio 43210, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC156121PMC
http://dx.doi.org/10.1128/mcb.23.12.4056-4065.2003DOI Listing
June 2003

A comprehensive search for DNA amplification in lung cancer identifies inhibitors of apoptosis cIAP1 and cIAP2 as candidate oncogenes.

Hum Mol Genet 2003 Apr;12(7):791-801

Program of Human Cancer Genetics, Department of Molecular Virology, Immunology and Medical Genetics, The Ohio State University, Columbus, OH, 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/hmg/ddg083DOI Listing
April 2003

LOH of chromosome 12p correlates with Kras2 mutation in non-small cell lung cancer.

Oncogene 2003 Feb;22(8):1243-6

Division of Human Cancer genetics, The Ohio Stsate University Comprehensive Cancer Center, 420 West 12th Avenue, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1206192DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3438910PMC
February 2003

An AscI boundary library for the studies of genetic and epigenetic alterations in CpG islands.

Genome Res 2002 Oct;12(10):1591-8

Division of Human Cancer Genetics, Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1101/gr.197402DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC187524PMC
October 2002